Supernus Pharmaceuticals (SUPN) Competitor Comparison
We are evaluating the key criteria listed to compare Supernus Pharmaceuticals (SUPN) against its competitors in the Drug Manufacturers - Specialty & Generic industry.
Market Capitalization
15 / 54Gross Profits
10 / 39Total Revenue
18 / 50EBITDA
16 / 53Free Cashflow
13 / 54Quick Ratio
34 / 54Earnings per Share
8 / 54Dividend yield
0 / 5Total Cash
16 / 54Performance 3 years
13 / 54Performance 5 years
7 / 54Performance 10 years
2 / 54Linearity 3 years
2 / 54Linearity 5 years
31 / 54Linearity 10 years
51 / 54Total Rank
49 / 54Dividend Rank
11 / 54Valuation Rank
49 / 54Piotroski Rank
3 / 54Muliplier Rank
54 / 54Free Cashflow - SUPN ranking 13 / 54
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.